Know Cancer

or
forgot password

Follow-up for Patients Previously Enrolled on the Center for Cancer Research Protocols


N/A
N/A
N/A
Open (Enrolling)
Both
Acquired Immunodeficiency Syndrome, Neoplasm, Skin Disease, HIV Infections

Thank you

Trial Information

Follow-up for Patients Previously Enrolled on the Center for Cancer Research Protocols


Background:

Patients enrolled on CCR clinical protocols may require long term follow-up to assess
outcome (e.g., survival) or the effects of prior therapy.

Keeping the primary treatment protocols open after accrual is complete in order to follow
patients for long term outcome is an administrative burden on investigators and the IRB.

Objectives:

To provide follow-up for patients who are long term survivors previously enrolled Center for
Cancer Research (CCR) trial but who may not currently be enrolled on a research protocol.

Eligibility:

Patients who were previously enrolled on a CCR protocol and who are not eligible for an
active NCI intramural primary research protocol.

Design:

The medical procedures/tests will be based on the patient's diagnosis, treatment and
supporting clinical information. This is a follow-up study in which only standard tests and
procedures are to be performed.

Clinical information that is relevant to the patients prior protocols will be collected for
research purposes.

Procedures that entail more than minimal risk to the patient should not be performed for
research purposes on this protocol.

Inclusion Criteria


- ELIGIBILITY CRITERIA:

Patients of any age who were previously enrolled on a CCR protocol.

Not eligible for or unwilling to participate in an active NCI intramural primary research
protocol.

CCR investigator decides it is in the best interests of the patient and the CC for the
patient to be seen in follow-up visits at the NIH.

Patient or guardian is able to provide informed consent.

Type of Study:

Observational

Study Design:

N/A

Principal Investigator

Caryn Steakley, R.N.

Investigator Role:

Principal Investigator

Investigator Affiliation:

National Cancer Institute (NCI)

Authority:

United States: Federal Government

Study ID:

960071

NCT ID:

NCT00001503

Start Date:

May 1996

Completion Date:

Related Keywords:

  • Acquired Immunodeficiency Syndrome
  • Neoplasm
  • Skin Disease
  • HIV Infections
  • Natural History
  • Neutropenia
  • Non-Therapeutic
  • Chronic Effects
  • Rare Diseases
  • Acquired Immunodeficiency Syndrome
  • HIV Infections
  • Neoplasms
  • Immunologic Deficiency Syndromes
  • Skin Diseases

Name

Location

National Institutes of Health Clinical Center, 9000 Rockville PikeBethesda, Maryland  20892